ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 25 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $5,000 | – | 21,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 12,079,080 | $27,178,000 | 0.29% |
| jvl associates llc | 58,500 | $132,000 | 0.13% |
| Sigma Planning Corp | 27,500 | $62,000 | 0.00% |
| NORTHWEST WEALTH MANAGEMENT, LLC | 280 | $1,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,158 | $9,000 | 0.00% |
| Ameritas Investment Partners, Inc. | 2,890 | $7,000 | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 60,388 | $136,000 | 0.00% |
| UBS Group AG | 9,495 | $21,000 | 0.00% |
| RHUMBLINE ADVISERS | 31,685 | $71,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1,290 | $2,902,000 | 0.00% |